Mani, Inc. (7730.T)
- Previous Close
1,212.50 - Open
1,237.00 - Bid 1,220.00 x --
- Ask 1,222.00 x --
- Day's Range
1,219.50 - 1,237.50 - 52 Week Range
1,044.50 - 2,161.00 - Volume
113,300 - Avg. Volume
554,289 - Market Cap (intraday)
120.173B - Beta (5Y Monthly) 0.18
- PE Ratio (TTM)
19.92 - EPS (TTM)
61.23 - Earnings Date Jul 3, 2025 - Jul 7, 2025
- Forward Dividend & Yield 46.00 (3.79%)
- Ex-Dividend Date Aug 28, 2025
- 1y Target Est
1,513.33
Mani, Inc. engages in the manufacture and distribution of medical devices and dental instruments in Japan and internationally. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, stainless wire needles, maniceps, septum stitch, and stent graft metal skeleton; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. In addition, the company imports and sells medical devices. The company was founded in 1956 and is headquartered in Utsunomiya, Japan.
www.mani.co.jpRecent News: 7730.T
View MorePerformance Overview: 7730.T
Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 7730.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 7730.T
View MoreValuation Measures
Market Cap
119.43B
Enterprise Value
100.88B
Trailing P/E
19.79
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.06
Price/Book (mrq)
2.24
Enterprise Value/Revenue
3.43
Enterprise Value/EBITDA
9.61
Financial Highlights
Profitability and Income Statement
Profit Margin
20.52%
Return on Assets (ttm)
9.13%
Return on Equity (ttm)
11.50%
Revenue (ttm)
29.42B
Net Income Avi to Common (ttm)
6.03B
Diluted EPS (ttm)
61.23
Balance Sheet and Cash Flow
Total Cash (mrq)
18.63B
Total Debt/Equity (mrq)
0.14%
Levered Free Cash Flow (ttm)
-1.62B